Short-term study of rTMS for migraine prevention

This is a clinical trial of the medical device Migraine Guard Pro, which is under development. It is intended to study the positive short-term effects for the treatment of migraine.

Research has shown that the stimulation protocol used by Migraine Guard Pro can prevent more than 50% of migraine attacks*.

The study will be conducted at the Vivea Gesundheitshotel Bad Vöslau (Badner Straße 7-9, 2540 Bad Vöslau)**.

NOTE: This is not a binding registration for participating in the study, but a consent to recieve for information.

Please enable JavaScript in your browser to complete this form.
Have you been diagnosed with migraine by a doctor?
I am ready to travel to Bad Vöslau (close to Vienna) for the study.
How did you find out about us?
Data Consent
This consent can be revoked at any time by calling Brightmind.AI GmbH (via e-mail to or by telephone). The revocation does not affect the lawfulness of the processing carried out up to that point.

*Cheng et al. (2022),